Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,773
Recruiting: 1,496
Ph III recruiting: 183
Growth YoY: +7.3%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,526)

clinicaltrialsPublishedShowing 101–150 of 1,317 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04273061	Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity(CAPTIV-8)	recruiting	Phase 2	50	British Columbia Cancer AgencyOTHER	1	Sep 16, 2026	clinicaltrials
NCT04486833	Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib(Acclaim-1)	recruiting	Phase 1 / Phase 2	158	Genprex, Inc.INDUSTRY	1